Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
September-2022 Volume 24 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
September-2022 Volume 24 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

PAD4 silencing inhibits inflammation whilst promoting trophoblast cell invasion and migration by inactivating the NEMO/NF‑κB pathway

  • Authors:
    • Min Zeng
    • Minjuan Xu
    • Xiafang Li
    • Junying Li
    • Yuanyuan Liu
  • View Affiliations / Copyright

    Affiliations: Department of Obstetrics, Ganzhou People's Hospital, Ganzhou, Jiangxi 341001, P.R. China
    Copyright: © Zeng et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 568
    |
    Published online on: July 12, 2022
       https://doi.org/10.3892/etm.2022.11505
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Preeclampsia (PE), presenting with onset hypertension and proteinuria, is a pregnancy‑specific disorder that can result in maternal and fetal morbidity and mortality. Insufficient trophoblast invasion and migration has been considered to be an important cause of this disease. The present study aimed to investigate the role of peptidyl arginine deiminase 4 (PAD4), whose knockdown has been previously indicated to reduce inflammation and susceptibility to pregnancy loss in mice, in the development of PE in vitro. Lipopolysaccharide (LPS) was used to treat a human trophoblast cell line (HTR8/SVneo). After PAD4 silencing via transfection with short hairpin RNA against PAD4, the concentrations of inflammatory factors IL‑6, IL‑12 and monocyte chemoattractant protein (MCP)‑1 were measured using ELISA. Cell viability was also measured using Cell Counting Kit‑8 assay. HTR8/SVneo cell invasion and migration were detected using Transwell and wound healing assays, respectively. Western blotting was used to measure the expression of citrullinated NF‑κB essential modulator (NEMO) and nuclear NF‑κB p65 protein levels. TNF‑α was applied for evaluating the potential regulatory effects of PAD4 on NF‑κB in LPS‑stimulated HTR8/SVneo cells. LPS increased the levels of IL‑6, IL‑12 and MCP‑1 and reduced the migration and invasion of HTR8/SVneo cells. PAD4‑knockdown was found to markedly reduce the levels of IL‑6, IL‑12 and MCP‑1 secretion. HTR8/SVneo cell invasion and migration was also significantly elevated after PAD4 silencing following LPS exposure. In addition, LPS stimulation notably upregulated the protein levels of citrullinated NEMO and nuclear NF‑κB p65, which was restored by PAD4 knockdown. Furthermore, TNF‑α treatment partially counteracted the effects of PAD4 knockdown on the secretion of IL‑6, MCP‑1 and IL‑12, which are markers of inflammation, and invasion and migration in LPS‑induced HTR8/SVneo cells. To conclude, these results suggest that PAD4 silencing can suppress inflammation whilst promoting invasion and migration by trophoblast cells through inhibiting the NEMO/NF‑κB pathway. These findings furthered the understanding in the complex molecular mechanism that can trigger PE and provide a promising target for the treatment of this disease.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

Capriglione S, Plotti F, Terranova C, Gulino FA, Di Guardo F, Lopez S, Scaletta G and Angioli R: Preeclampsia and the challenge of early prediction: Reality or utopia? State of art and critical review of literature. J Matern Fetal Neonatal Med. 33:677–686. 2020.PubMed/NCBI View Article : Google Scholar

2 

Mazzuca MQ, Li W, Reslan OM, Yu P, Mata KM and Khalil RA: Downregulation of microvascular endothelial type B endothelin receptor is a central vascular mechanism in hypertensive pregnancy. Hypertension. 64:632–643. 2014.PubMed/NCBI View Article : Google Scholar

3 

Li X, Wu C, Shen Y, Wang K, Tang L, Zhou M, Yang M, Pan T, Liu X and Xu W: Ten-eleven translocation 2 demethylates the MMP9 promoter, and its down-regulation in preeclampsia impairs trophoblast migration and invasion. J Biol Chem. 293:10059–10070. 2018.PubMed/NCBI View Article : Google Scholar

4 

Xie N, Jia Z and Li L: miR-320a upregulation contributes to the development of preeclampsia by inhibiting the growth and invasion of trophoblast cells by targeting interleukin 4. Mol Med Rep. 20:3256–3264. 2019.PubMed/NCBI View Article : Google Scholar

5 

Rohrbach AS, Slade DJ, Thompson PR and Mowen KA: Activation of PAD4 in NET formation. Front Immunol. 3(360)2012.PubMed/NCBI View Article : Google Scholar

6 

Wang S and Wang Y: Peptidylarginine deiminases in citrullination, gene regulation, health and pathogenesis. Biochim Biophys Acta. 1829:1126–1135. 2013.PubMed/NCBI View Article : Google Scholar

7 

Erpenbeck L, Chowdhury CS, Zsengellér ZK, Gallant M, Burke SD, Cifuni S, Hahn S, Wagner DD and Karumanchi SA: PAD4 deficiency decreases inflammation and susceptibility to pregnancy loss in a mouse model. Biol Reprod. 95(132)2016.PubMed/NCBI View Article : Google Scholar

8 

Rabadi M, Kim M, D'Agati V and Lee HT: Peptidyl arginine deiminase-4-deficient mice are protected against kidney and liver injury after renal ischemia and reperfusion. Am J Physiol Renal Physiol. 311:F437–F449. 2016.PubMed/NCBI View Article : Google Scholar

9 

Rabadi MM, Han SJ, Kim M, D'Agati V and Lee HT: Peptidyl arginine deiminase-4 exacerbates ischemic AKI by finding NEMO. Am J Physiol Renal Physiol. 316:F1180–F1190. 2019.PubMed/NCBI View Article : Google Scholar

10 

Vaughan JE and Walsh SW: Activation of NF-κB in placentas of women with preeclampsia. Hypertens Pregnancy. 31:243–251. 2012.PubMed/NCBI View Article : Google Scholar

11 

Sakowicz A, Lisowska M, Biesiada L, Płuciennik E, Gach A, Rybak-Krzyszkowska M, Huras H, Sakowicz B, Romanowicz H, Piastowska-Ciesielska AW, et al: Placental expression of NEMO protein in normal pregnancy and preeclampsia. Dis Markers. 2019(8418379)2019.PubMed/NCBI View Article : Google Scholar

12 

Sakowicz A, Hejduk P, Pietrucha T, Nowakowska M, Płuciennik E, Pospiech K, Gach A, Rybak-Krzyszkowska M, Sakowicz B, Kaminski M, et al: Finding NEMO in preeclampsia. Am J Obstet Gynecol. 214:538.e1–538.e7. 2016.PubMed/NCBI View Article : Google Scholar

13 

Sakowicz A, Pietrucha T, Rybak-Krzyszkowska M, Huras H, Gach A, Sakowicz B, Banaszczyk M, Grzesiak M and Biesiada L: Double hit of NEMO gene in preeclampsia. PLoS One. 12(e0180065)2017.PubMed/NCBI View Article : Google Scholar

14 

Hu J, Zhang J and Zhu B: Protective effect of metformin on a rat model of lipopolysaccharide-induced preeclampsia. Fundam Clin Pharmacol. 33:649–658. 2019.PubMed/NCBI View Article : Google Scholar

15 

Graham CH, Hawley TS, Hawley RG, MacDougall JR, Kerbel RS, Khoo N and Lala PK: Establishment and characterization of first trimester human trophoblast cells with extended lifespan. Exp Cell Res. 206:204–211. 1993.PubMed/NCBI View Article : Google Scholar

16 

Abou-Kheir W, Barrak J, Hadadeh O and Daoud G: HTR-8/SVneo cell line contains a mixed population of cells. Placenta. 50:1–7. 2017.PubMed/NCBI View Article : Google Scholar

17 

Fan M, Li X, Gao X, Dong L, Xin G, Chen L, Qiu J and Xu Y: LPS induces preeclampsia-like phenotype in rats and HTR8/SVneo cells dysfunction through TLR4/p38 MAPK pathway. Front Physiol. 10(1030)2019.PubMed/NCBI View Article : Google Scholar

18 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar

19 

Jena MK, Sharma NR, Petitt M, Maulik D and Nayak NR: Pathogenesis of preeclampsia and therapeutic approaches targeting the placenta. Biomolecules. 10(953)2020.PubMed/NCBI View Article : Google Scholar

20 

Calicchio R, Buffat C, Vaiman D and Miralles F: Endothelial dysfunction: Role in the maternal syndrome of preeclampsia and long-term consequences for the cardiovascular system. Ann Cardiol Angeiol (Paris). 62:215–220. 2013.PubMed/NCBI View Article : Google Scholar : (In French).

21 

Pauli JM and Repke JT: Preeclampsia: Short-term and long-term implications. Obstet Gynecol Clin North Am. 42:299–313. 2015.PubMed/NCBI View Article : Google Scholar

22 

Dai X and Cai Y: Down-regulation of microRNA let-7d inhibits the proliferation and invasion of trophoblast cells in preeclampsia. J Cell Biochem. 119:1141–1151. 2018.PubMed/NCBI View Article : Google Scholar

23 

Shaw J, Tang Z, Schneider H, Saljé K, Hansson SR and Guller S: Inflammatory processes are specifically enhanced in endothelial cells by placental-derived TNF-α: Implications in preeclampsia (PE). Placenta. 43:1–8. 2016.PubMed/NCBI View Article : Google Scholar

24 

Harmon AC, Cornelius DC, Amaral LM, Faulkner JL, Cunningham MW Jr, Wallace K and LaMarca B: The role of inflammation in the pathology of preeclampsia. Clin Sci (Lond). 130:409–419. 2016.PubMed/NCBI View Article : Google Scholar

25 

Cotechini T, Komisarenko M, Sperou A, Macdonald-Goodfellow S, Adams MA and Graham CH: Inflammation in rat pregnancy inhibits spiral artery remodeling leading to fetal growth restriction and features of preeclampsia. J Exp Med. 211:165–179. 2014.PubMed/NCBI View Article : Google Scholar

26 

Kadam L, Kilburn B, Baczyk D, Kohan-Ghadr HR, Kingdom J and Drewlo S: Rosiglitazone blocks first trimester in-vitro placental injury caused by NF-κB-mediated inflammation. Sci Rep. 9(2018)2019.PubMed/NCBI View Article : Google Scholar

27 

Zaga-Clavellina V, Garcia-Lopez G, Flores-Herrera H, Espejel-Nuñez A, Flores-Pliego A, Soriano-Becerril D, Maida-Claros R, Merchant-Larios H and Vadillo-Ortega F: In vitro secretion profiles of interleukin (IL)-1beta, IL-6, IL-8, IL-10, and TNF alpha after selective infection with Escherichia coli in human fetal membranes. Reprod Biol Endocrinol. 5(46)2007.PubMed/NCBI View Article : Google Scholar

28 

Vossenaar ER, Nijenhuis S, Helsen MM, van der Heijden A, Senshu T, van den Berg WB, van Venrooij WJ and Joosten LA: Citrullination of synovial proteins in murine models of rheumatoid arthritis. Arthritis Rheum. 48:2489–2500. 2003.PubMed/NCBI View Article : Google Scholar

29 

Shelef MA, Sokolove J, Lahey LJ, Wagner CA, Sackmann EK, Warner TF, Wang Y, Beebe DJ, Robinson WH and Huttenlocher A: Peptidylarginine deiminase 4 contributes to tumor necrosis factor α-induced inflammatory arthritis. Arthritis Rheumatol. 66:1482–1491. 2014.PubMed/NCBI View Article : Google Scholar

30 

Li H, Han SJ, Kim M, Cho A, Choi Y, D'Agati V and Lee HT: Divergent roles for kidney proximal tubule and granulocyte PAD4 in ischemic AKI. Am J Physiol Renal Physiol. 314:F809–F819. 2018.PubMed/NCBI View Article : Google Scholar

31 

Lorquet S, Pequeux C, Munaut C and Foidart JM: Aetiology and physiopathology of preeclampsia and related forms. Acta Clin Belg. 65:237–241. 2010.PubMed/NCBI View Article : Google Scholar

32 

Martin E, Ray PD, Smeester L, Grace MR, Boggess K and Fry RC: Epigenetics and preeclampsia: Defining functional epimutations in the preeclamptic placenta related to the TGF-β pathway. PLoS One. 10(e0141294)2015.PubMed/NCBI View Article : Google Scholar

33 

Walker JJ: Pre-eclampsia. Lancet. 356:1260–1265. 2000.PubMed/NCBI View Article : Google Scholar

34 

Jiang Y and Chen Y and Chen Y: Knockdown of JARID2 inhibits the viability and migration of placenta trophoblast cells in preeclampsia. Mol Med Rep. 16:3594–3599. 2017.PubMed/NCBI View Article : Google Scholar

35 

Chen D, Yu M, Chen H, Zeng M, Sun Y and Huang Q: Identification and functional characterization of NEMO in Crassostrea gigas reveals its crucial role in the NF-κB activation. Fish Shellfish Immunol. 80:46–55. 2018.PubMed/NCBI View Article : Google Scholar

36 

Ali Z, Zafar U, Khaliq S and Lone KP: Elevated tumor necrosis factor (TNF)-α mRNA expression correlates with nuclear factor kappa B expression in peripheral blood mononuclear cells in preeclampsia. J Coll Physicians Surg Pak. 30:158–162. 2020.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Zeng M, Xu M, Li X, Li J and Liu Y: PAD4 silencing inhibits inflammation whilst promoting trophoblast cell invasion and migration by inactivating the NEMO/NF‑κB pathway. Exp Ther Med 24: 568, 2022.
APA
Zeng, M., Xu, M., Li, X., Li, J., & Liu, Y. (2022). PAD4 silencing inhibits inflammation whilst promoting trophoblast cell invasion and migration by inactivating the NEMO/NF‑κB pathway. Experimental and Therapeutic Medicine, 24, 568. https://doi.org/10.3892/etm.2022.11505
MLA
Zeng, M., Xu, M., Li, X., Li, J., Liu, Y."PAD4 silencing inhibits inflammation whilst promoting trophoblast cell invasion and migration by inactivating the NEMO/NF‑κB pathway". Experimental and Therapeutic Medicine 24.3 (2022): 568.
Chicago
Zeng, M., Xu, M., Li, X., Li, J., Liu, Y."PAD4 silencing inhibits inflammation whilst promoting trophoblast cell invasion and migration by inactivating the NEMO/NF‑κB pathway". Experimental and Therapeutic Medicine 24, no. 3 (2022): 568. https://doi.org/10.3892/etm.2022.11505
Copy and paste a formatted citation
x
Spandidos Publications style
Zeng M, Xu M, Li X, Li J and Liu Y: PAD4 silencing inhibits inflammation whilst promoting trophoblast cell invasion and migration by inactivating the NEMO/NF‑κB pathway. Exp Ther Med 24: 568, 2022.
APA
Zeng, M., Xu, M., Li, X., Li, J., & Liu, Y. (2022). PAD4 silencing inhibits inflammation whilst promoting trophoblast cell invasion and migration by inactivating the NEMO/NF‑κB pathway. Experimental and Therapeutic Medicine, 24, 568. https://doi.org/10.3892/etm.2022.11505
MLA
Zeng, M., Xu, M., Li, X., Li, J., Liu, Y."PAD4 silencing inhibits inflammation whilst promoting trophoblast cell invasion and migration by inactivating the NEMO/NF‑κB pathway". Experimental and Therapeutic Medicine 24.3 (2022): 568.
Chicago
Zeng, M., Xu, M., Li, X., Li, J., Liu, Y."PAD4 silencing inhibits inflammation whilst promoting trophoblast cell invasion and migration by inactivating the NEMO/NF‑κB pathway". Experimental and Therapeutic Medicine 24, no. 3 (2022): 568. https://doi.org/10.3892/etm.2022.11505
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team